DNA-encoded fetal liver tyrosine kinase 3 ligand and granulocyte macrophage-colony-stimulating factor increase dendritic cell recruitment to the inoculation site and enhance antigen-specific CD4+ T cell responses induced by DNA vaccination of outbred animals.
DNA-based immunization is a contemporary strategy for developing vaccines to prevent infectious diseases in animals and humans. Translating the efficacy of DNA immunization demonstrated in murine models to the animal species that represent the actual populations to be protected remains a significant challenge. We tested two hypotheses directed at enhancing DNA vaccine efficacy in outbred animals. The first hypothesis, that DNA-encoding fetal liver tyrosine kinase 3 ligand (Flt3L) and GM-CSF increases dendritic cell (DC) recruitment to the immunization site, was tested by intradermal inoculation of calves with plasmid DNA encoding Flt3L and GM-CSF followed by quantitation of CD1(+) DC. Peak DC recruitment was detected at 10-15 days postinoculation and was significantly greater (p < 0.05) in calves in the treatment group as compared with control calves inoculated identically, but without Flt3L and GM-CSF. The second hypothesis, that DNA encoding Flt3L and GM-CSF enhances immunity to a DNA vector-expressed Ag, was tested by analyzing the CD4(+) T lymphocyte response to Anaplasma marginale major surface protein 1a (MSP1a). Calves immunized with DNA-expressing MSP1a developed strong CD4(+) T cell responses against A. marginale, MSP1a, and specific MHC class II DR-restricted MSP1a epitopes. Administration of DNA-encoding Flt3L and GM-CSF before MSP1a DNA vaccination significantly increased the population of Ag-specific effector/memory cells in PBMC and significantly enhanced MSP1a-specific CD4(+) T cell proliferation and IFN-gamma secretion as compared with MHC class II DR-matched calves vaccinated identically but without Flt3L and GM-CSF. These results support use of these growth factors in DNA vaccination and specifically indicate their applicability for vaccine testing in outbred animals.
Mwangi
Waithaka
W
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99164, USA. waitham@vetmed.wsu.edu
Brown
Wendy C
WC
Lewin
Harris A
HA
Howard
Chris J
CJ
Hope
Jayne C
JC
Baszler
Timothy V
TV
Caplazi
Patrick
P
Abbott
Jeffrey
J
Palmer
Guy H
GH
D000276:Adjuvants, Immunologic / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D000279:Administration, Cutaneous; D000709:Anaplasma / Q000235:genetics / Q000276:immunology; D000818:Animals; D001425:Bacterial Outer Membrane Proteins / Q000008:administration & dosage / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D001947:Breeding; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D002417:Cattle; D002460:Cell Line; D002465:Cell Movement / Q000235:genetics / Q000276:immunology*; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000276:immunology; D005110:Extracellular Space / Q000235:genetics / Q000276:immunology; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D007371:Interferon-gamma / Q000096:biosynthesis; D008024:Ligands; D008297:Male; D008565:Membrane Proteins / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D010957:Plasmids / Q000096:biosynthesis; D017434:Protein Structure, Tertiary / Q000235:genetics; D019444:Vaccines, DNA / Q000008:administration & dosage* / Q000096:biosynthesis / Q000235:genetics
D000276:Adjuvants, Immunologic; D001425:Bacterial Outer Membrane Proteins; D018984:Epitopes, T-Lymphocyte; D008024:Ligands; D008565:Membrane Proteins; D019444:Vaccines, DNA; C084881:flt3 ligand protein; C449089:major surface protein 1a, Anaplasma; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor